Rosmantuzumab
Rosmantuzumab is a monoclonal antibody designed for the treatment of cancer. This drug was developed by Roche.
History[edit]
Rosmantuzumab was developed by the pharmaceutical company Roche. It is a monoclonal antibody, a type of drug that is designed to bind to specific proteins in the body. In the case of rosmantuzumab, it is designed to bind to a protein that is often overexpressed in cancer cells.
Mechanism of Action[edit]
The exact mechanism of action of rosmantuzumab is not fully understood. However, it is known that it works by binding to a specific protein on the surface of cancer cells. This binding can trigger an immune response that can lead to the destruction of the cancer cells.
Clinical Trials[edit]
Rosmantuzumab has been tested in several clinical trials for its effectiveness in treating various types of cancer. The results of these trials have been mixed, with some showing promise and others showing little to no effect.
Side Effects[edit]
Like all drugs, rosmantuzumab can cause side effects. The most common side effects reported in clinical trials include fatigue, nausea, and diarrhea. More serious side effects can include allergic reactions and immune-related adverse events.
Future Research[edit]
Future research on rosmantuzumab will likely focus on determining the types of cancer for which it is most effective, as well as further elucidating its mechanism of action. Additionally, researchers will continue to monitor its safety profile in larger patient populations.
See Also[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian